Answers are grounded in this paper and cite their sources.
These findings support that prior DENV infection may protect individuals from symptomatic Zika. More research is needed to address the possible immunological mechanism(s) of cross-protection between ZIKV and DENV and whether DENV immunity also modulates other ZIKV infection outcomes such as neurological or congenital syndromes.
No takes yet. Share an insight, caveat, or question.
Gordon et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: